Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
Clinical trial NCT04412252 · WITHDRAWN
Trial details
- NCT number
- NCT04412252
- Sponsor
- Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2020-09-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.